Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Raskin

Showing results (51-60 of 197) with videos related to

Pageof 20
Sort By:
Diabetes|April 1, 1978
Effect of insulin therapy on the profiles of plasma immunoreactive glucagon in juvenile-type and adult-type diabeticsP Raskin, R H Unger
Endocrinology and Metabolism Clinics of North America|June 1, 1992
Management of hypertension in diabetesC Arauz-Pacheco, P Raskin
The Medical Clinics of North America|July 1, 1978
Glucagon and diabetesP Raskin, R H Unger
The American Journal of Medicine|September 18, 1987
Conversion from low-dose insulin therapy to glipizide in patients with non-insulin-dependent diabetes mellitusJ Rosenstock, A Meisel, P Raskin
Diabetic Medicine : a Journal of the British Diabetic Association|April 1, 1991
Increased erythrocyte aldose reductase activity in type 1 diabetic patientsY Hamada, R Kito, P Raskin
AJR. American Journal of Roentgenology|August 1, 1982
Recognition of lumbar disk disease: comparison of myelography and computed tomographyS P Raskin, J W Keating
Diabetic Medicine : a Journal of the British Diabetic Association|January 1, 1993
Association of erythrocyte aldose reductase activity with diabetic complications in type 1 diabetes mellitusY Hamada, R Kitoh, P Raskin
Journal of Diabetes and Its Complications|April 1, 1992
No correlation between glycemic control and an increase in erythrocyte aldose reductase activity in type I and type II diabetic patientsY Hamada, K Hammon, P Raskin
The American Journal of Medicine|December 1, 1986
Effect of glycemic control on microvascular complications in patients with type I diabetes mellitusJ Rosenstock, T Friberg, P Raskin
The American Review of Respiratory Disease|April 1, 1975
Interacinar pathways in the human lungS P Raskin, P G Herman
Pageof 20

Showing results (51-60 of 197) with videos related to

Sort By:
Pageof 20
Diabetes|April 1, 1978
Effect of insulin therapy on the profiles of plasma immunoreactive glucagon in juvenile-type and adult-type diabeticsP Raskin, R H Unger
Endocrinology and Metabolism Clinics of North America|June 1, 1992
Management of hypertension in diabetesC Arauz-Pacheco, P Raskin
The Medical Clinics of North America|July 1, 1978
Glucagon and diabetesP Raskin, R H Unger
The American Journal of Medicine|September 18, 1987
Conversion from low-dose insulin therapy to glipizide in patients with non-insulin-dependent diabetes mellitusJ Rosenstock, A Meisel, P Raskin
Diabetic Medicine : a Journal of the British Diabetic Association|April 1, 1991
Increased erythrocyte aldose reductase activity in type 1 diabetic patientsY Hamada, R Kito, P Raskin
AJR. American Journal of Roentgenology|August 1, 1982
Recognition of lumbar disk disease: comparison of myelography and computed tomographyS P Raskin, J W Keating
Diabetic Medicine : a Journal of the British Diabetic Association|January 1, 1993
Association of erythrocyte aldose reductase activity with diabetic complications in type 1 diabetes mellitusY Hamada, R Kitoh, P Raskin
Journal of Diabetes and Its Complications|April 1, 1992
No correlation between glycemic control and an increase in erythrocyte aldose reductase activity in type I and type II diabetic patientsY Hamada, K Hammon, P Raskin
The American Journal of Medicine|December 1, 1986
Effect of glycemic control on microvascular complications in patients with type I diabetes mellitusJ Rosenstock, T Friberg, P Raskin
The American Review of Respiratory Disease|April 1, 1975
Interacinar pathways in the human lungS P Raskin, P G Herman
Pageof 20